These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 21670845)

  • 1. Stabilisation of atherosclerotic plaques. Position paper of the European Society of Cardiology (ESC) Working Group on atherosclerosis and vascular biology.
    Ylä-Herttuala S; Bentzon JF; Daemen M; Falk E; Garcia-Garcia HM; Herrmann J; Hoefer I; Jukema JW; Krams R; Kwak BR; Marx N; Naruszewicz M; Newby A; Pasterkamp G; Serruys PW; Waltenberger J; Weber C; Tokgözoglu L
    Thromb Haemost; 2011 Jul; 106(1):1-19. PubMed ID: 21670845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From pathophysiology to targeted therapy for atherothrombosis: a role for the combination of statin and aspirin in secondary prevention.
    Chapman MJ
    Pharmacol Ther; 2007 Jan; 113(1):184-96. PubMed ID: 17070923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contemporary rationale for non-invasive imaging of adverse coronary plaque features to identify the vulnerable patient: a Position Paper from the European Society of Cardiology Working Group on Atherosclerosis and Vascular Biology and the European Association of Cardiovascular Imaging.
    Dweck MR; Maurovich-Horvat P; Leiner T; Cosyns B; Fayad ZA; Gijsen FJH; Van der Heiden K; Kooi ME; Maehara A; Muller JE; Newby DE; Narula J; Pontone G; Regar E; Serruys PW; van der Steen AFW; Stone PH; Waltenberger JL; Yuan C; Evans PC; Lutgens E; Wentzel JJ; Bäck M
    Eur Heart J Cardiovasc Imaging; 2020 Oct; 21(11):1177-1183. PubMed ID: 32887997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dyslipidemia, atherosclerosis, and vulnerable plaques: the effect of atorvastatin on atherosclerosis and plaque structure].
    Tokgözoğlu L
    Turk Kardiyol Dern Ars; 2009 Mar; 37 Suppl 2():11-6. PubMed ID: 19404045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque?
    Akdim F; van Leuven SI; Kastelein JJ; Stroes ES
    Curr Pharm Des; 2007; 13(10):1003-12. PubMed ID: 17430164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Traditional Chinese medication Tongxinluo dose-dependently enhances stability of vulnerable plaques: a comparison with a high-dose simvastatin therapy.
    Zhang L; Liu Y; Lu XT; Wu YL; Zhang C; Ji XP; Wang R; Liu CX; Feng JB; Jiang H; Xu XS; Zhao YX; Zhang Y
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2004-14. PubMed ID: 19801495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thrombosis formation on atherosclerotic lesions and plaque rupture.
    Badimon L; Vilahur G
    J Intern Med; 2014 Dec; 276(6):618-32. PubMed ID: 25156650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do we know enough about the immune pathogenesis of acute coronary syndromes to improve clinical practice?
    Matusik P; Guzik B; Weber C; Guzik TJ
    Thromb Haemost; 2012 Sep; 108(3):443-56. PubMed ID: 22872109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization.
    Stoll G; Bendszus M
    Stroke; 2006 Jul; 37(7):1923-32. PubMed ID: 16741184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intensive lipid lowering therapy with titrated rosuvastatin yields greater atherosclerotic aortic plaque regression: Serial magnetic resonance imaging observations from RAPID study.
    Yogo M; Sasaki M; Ayaori M; Kihara T; Sato H; Takiguchi S; Uto-Kondo H; Yakushiji E; Nakaya K; Komatsu T; Momiyama Y; Nagata M; Mochio S; Iguchi Y; Ikewaki K
    Atherosclerosis; 2014 Jan; 232(1):31-9. PubMed ID: 24401214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerotic plaque regression: fact or fiction?
    Shanmugam N; Román-Rego A; Ong P; Kaski JC
    Cardiovasc Drugs Ther; 2010 Aug; 24(4):311-7. PubMed ID: 20549322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atherosclerosis, Periodontal Disease, and Treatment with Resolvins.
    Hamilton JA; Hasturk H; Kantarci A; Serhan CN; Van Dyke T
    Curr Atheroscler Rep; 2017 Nov; 19(12):57. PubMed ID: 29110146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Statins and antiplatelet agents: complementary mechanisms of action at the coronary artery level].
    Chapman J
    Am J Cardiovasc Drugs; 2007; 7 Spec No 1():5-8. PubMed ID: 19839181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostaglandin E1 dose-dependently promotes stability of atherosclerotic plaque in a rabbit model.
    Bai W; Zheng X; Zhou L; Li H
    Can J Physiol Pharmacol; 2012 Feb; 90(2):131-9. PubMed ID: 22309388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recognition, pathophysiology, and management of acute myocardial infarction.
    Cheng JW
    Am J Health Syst Pharm; 2001 Sep; 58(18):1709-18; quiz 1719-21. PubMed ID: 11571813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined effects of HMG-CoA-reductase inhibition and renin-angiotensin system blockade on experimental atherosclerosis.
    Grothusen C; Bley S; Selle T; Luchtefeld M; Grote K; Tietge UJ; Drexler H; Schieffer B
    Atherosclerosis; 2005 Sep; 182(1):57-69. PubMed ID: 16115475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal medical management of peripheral arterial disease.
    Rice TW; Lumsden AB
    Vasc Endovascular Surg; 2006; 40(4):312-27. PubMed ID: 16959725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of statins on high-risk atherosclerotic plaque associated with low endothelial shear stress.
    Takahashi S; Papafaklis MI; Sakamoto S; Antoniadis AP; Coskun AU; Feldman CL; Stone PH
    Curr Opin Lipidol; 2011 Oct; 22(5):358-64. PubMed ID: 21841484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tandem Stenosis to Induce Atherosclerotic Plaque Instability in the Mouse.
    Chen YC; Rivera J; Peter K
    Methods Mol Biol; 2015; 1339():333-8. PubMed ID: 26445800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utility of Lp-PLA2 in lipid-lowering therapy.
    Racherla S; Arora R
    Am J Ther; 2012 Mar; 19(2):115-20. PubMed ID: 20634673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.